Yet medical organizations must establish unambiguous rules about patient and parental access to electronic patient portals. We conducted a national interview study to characterize the diversity in adolescent portal policies across a range of institutions and determine the factors influencing decisions about ...
b. Dans la zone de texteURL de réponse, tapez une URL au format suivant :https://<Portal_Domain>/AuthServices/Acs c. Dans la zone de texteURL de connexion, saisissez une URL au format suivant :https://<Portal_Domain> Notes Il ne s’agit pas de valeurs réelles. Mettez à jour ce...
SélectionnezSumTotalCentraldans le volet de résultats, puis ajoutez l’application. Patientez quelques secondes pendant que l’application est ajoutée à votre locataire. Vous pouvez également utiliser l’assistant Entreprise App Configuration. Dans cet assistant, vous pouvez ajouter une application ...
Randox offer a range of high performance, unique and niche reagents that are designed to enhance your laboratory testing capabilities. Our impressive portfolio of high performance & unique tests together with our standard assays sets us apart in the in vitro diagnostics market. Our superior performanc...
Late-onset inferior vena cava obstruction in a shunted patient—a unique cause of rebleeding in children with portal hypertensionJonesV. S.Prakash SundarajA.O'LoughlinE. V.StormonM.LordD. J.OPTICS COMMUNICATIONS
Background Rebleeding in the presence of an adequate patent portosystemic shunt in a patient with portal hypertension (PHT) is uncommon. Inferior vena cava (IVC) obstruction as the cause of rebleeding in this situation has not been reported in the literature. Methods Records from a pediatric ...
Traditional gynecological drugs are distributed evenly throughout the body: they enter the center of the disease and the healthy organs. Targeted delivery of a drug with a biodegradable polymer can solve the problem, then the drug will not be released instantly, but the polymer will shrink. ...